CVTYF yields 4.73% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, CVTYF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CVTYF + JNJ for your $10,000?
Coventry Group Ltd primarily distributes industrial products in Australia and New Zealand. The company operates through Trade Distribution and Fluids Systems segments. The Trade Distribution segment imports, distributes, and markets industrial fasteners, stainless steel fasteners, industrial hardware, construction fasteners, specialized fastener products and systems, and associated industrial tools and consumables. This segment also imports, distributes, and markets hardware, components, and finished products to the commercial cabinet making, joinery, and shop fitting industries; and engages in hiring and sale of fencing, as well as scaffolding plank hire activities. The Fluids Systems segment designs and installs lubrication systems; distributes hoses, connectors, fittings, and hydraulic hose assemblies; designs and supplies service truck components; installs fire suppression systems; designs and distributes fluid handling systems, as well as sells pneumatic components, and hydraulic associated products and consumables; and services and repairs rock hammers. Coventry Group Ltd was incorporated in 1936 and is headquartered in Thomastown, Australia.
Full CVTYF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.